We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70
Avg Time Held
12 quarters
Top 10 Avg Time Held
12 quarters
Top 20 Avg Time Held
10.4 quarters

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MMM icon
151
3M
MMM
$83.4B
$9.89M 0.1%
96,746
+4,451
+5% +$434K
2020 Q2
16 quarters
CME icon
152
CME Group
CME
$100B
$9.74M 0.1%
49,533
-1,059
-2% -$219K
2020 Q2
16 quarters
SPG icon
153
Simon Property Group
SPG
$65B
$9.72M 0.1%
64,047
+1,489
+2% +$219K
2020 Q2
16 quarters
ADM icon
154
Archer Daniels Midland
ADM
$39.1B
$9.57M 0.1%
158,309
+85,445
+117% +$5.24M
2020 Q2
16 quarters
SMCI icon
155
Super Micro Computer
SMCI
$26B
$9.49M 0.1%
115,850
+36,800
+47% +$3.15M
2022 Q4
6 quarters
FCX icon
156
Freeport-McMoran
FCX
$106B
$9.3M 0.1%
191,290
-52,846
-22% -$2.66M
2020 Q2
16 quarters
IDXX icon
157
Idexx Laboratories
IDXX
$41.3B
$9.29M 0.1%
19,071
+122
+0.6% +$61.2K
2020 Q2
16 quarters
SLB icon
158
SLB Ltd
SLB
$72.5B
$9.29M 0.09%
196,810
-2,505
-1% -$121K
2020 Q2
16 quarters
MO icon
159
Altria Group
MO
$119B
$9.15M 0.09%
200,875
-7,473
-4% -$332K
2020 Q2
16 quarters
GD icon
160
General Dynamics
GD
$90.6B
$9.14M 0.09%
31,516
-4,751
-13% -$1.39M
2020 Q2
16 quarters
IWF icon
161
iShares Russell 1000 Growth ETF
IWF
$130B
$9.13M 0.09%
100,224
+61,044
+156% +$5.21M
2020 Q2
16 quarters
BDX icon
162
Becton Dickinson
BDX
$51B
$9.12M 0.09%
39,035
-237
-0.6% -$55.8K
2020 Q2
16 quarters
MAR icon
163
Marriott International
MAR
$96.3B
$9.05M 0.09%
37,441
-22,679
-38% -$5.44M
2020 Q2
16 quarters
APO icon
164
Apollo Global Management
APO
$70.3B
$9M 0.09%
76,221
-12,406
-14% -$1.41M
2022 Q1
9 quarters
MPWR icon
165
Monolithic Power Systems
MPWR
$65.5B
$8.99M 0.09%
10,937
+188
+2% +$136K
2020 Q2
16 quarters
PLTR icon
166
Palantir
PLTR
$500B
$8.89M 0.09%
350,849
+16,679
+5% +$376K
2021 Q2
12 quarters
MPC icon
167
Marathon Petroleum
MPC
$129B
$8.85M 0.09%
51,037
+370
+0.7% +$68.8K
2020 Q2
16 quarters
EMR icon
168
Emerson Electric
EMR
$91B
$8.84M 0.09%
80,217
-427
-0.5% -$47.2K
2020 Q2
16 quarters
CSX icon
169
CSX Corp
CSX
$88.1B
$8.83M 0.09%
263,969
-23,392
-8% -$794K
2020 Q2
16 quarters
TFC icon
170
Truist Financial
TFC
$56.9B
$8.77M 0.09%
225,746
+42,585
+23% +$1.61M
2020 Q2
16 quarters
PH icon
171
Parker-Hannifin
PH
$122B
$8.62M 0.09%
17,041
-11
-0.1% -$5.9K
2020 Q2
16 quarters
IRM icon
172
Iron Mountain
IRM
$34.1B
$8.61M 0.09%
96,057
+39,442
+70% +$3.19M
2020 Q2
16 quarters
PYPL icon
173
PayPal
PYPL
$47.9B
$8.6M 0.09%
148,282
-110,572
-43% -$7.03M
2020 Q2
16 quarters
FIS icon
174
Fidelity National Information Services
FIS
$17.5B
$8.55M 0.09%
113,465
+33,066
+41% +$2.45M
2020 Q2
16 quarters
EW icon
175
Edwards Lifesciences
EW
$49.3B
$8.53M 0.09%
92,293
-46,106
-33% -$4.08M
2020 Q2
16 quarters

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.